Active — Not RecruitingNot Applicable

Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)

United States749 participantsStarted 2019-09-30

Plain-language summary

The investigators are conducting a 5-year prospective, 2:1 cluster-randomized controlled trial, funded by the Centers for Disease Control (CDC), which provides vision screenings to underserved New York City residents living in affordable housing buildings in Harlem and Washington Heights.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Individuals over age 40 * Living independently in NYCHA housing building or attending DFTA Senior Center * Willing to answer COVID-19 symptom questions * Willing to consent for 2 vision screening visits at baseline and 12-month follow-up Exclusion Criteria: * Self-reported terminal illness with life expectancy less than 1 year * Inability to provide informed consent due to dementia or other reasons

What they're measuring

Proportion of Subjects with Visual Acuity Worse than 20/40

Timeframe: 2 years

Trial details

NCT IDNCT04271709

SponsorColumbia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-09-29

View on ClinicalTrials.gov More Glaucoma trials